Evaluation of neuropsychiatric symptoms in patients with multiple sclerosis

Objective & Hypothesis:Purpose: The aim of this study was to comprehensively assess the neurophyschiatric symptoms of multiple sclerosis (MS) such as apathy and pseudobulbar affect and their correlation with other concomitant factors.

📊

Key Findings & Data:Materials and Methods: Montreal Cognitive Assessment (MoCA), Apathy Evaluation Scale (AES), Fatigue severity scale (FSS), Center for Neurologic Study-Lability Scale (CNS-LS), Beck Depression Inventory (BDI) are applied to 258 MS patients.

💡

Conclusion & Impact:Also, apathy may be an independent neuropyschiatric symptom of MS that need to be approached separately.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:apati · psödobulbar etkiler · apathy

Abstract

Purpose: The aim of this study was to comprehensively assess the neurophyschiatric symptoms of multiple sclerosis (MS) such as apathy and pseudobulbar affect and their correlation with other concomitant factors. Materials and Methods: Montreal Cognitive Assessment (MoCA), Apathy Evaluation Scale (AES), Fatigue severity scale (FSS), Center for Neurologic Study-Lability Scale (CNS-LS), Beck Depression Inventory (BDI) are applied to 258 MS patients. Correlation and regression analysis are conducted between scales and other possible causers. Results: 53.6% of the patients have psuedobulbar affect, 76.2% of patient population have fatigue. Pseudobulbar affect had positive correlation with fatigue and also depression while apathy negatively correlate with pseudobulbar affect or fatigue. Additionally, apathy and depression correlated negatively. There was no relation between cognition and depression and/or disease duration and/or other scales’ scores. Conclusion: Pseudobulbar affect and apathy are quite common symptoms in MS patients, that are cross-cutting issues. Also, apathy may be an independent neuropyschiatric symptom of MS that need to be approached separately.

Özet

Amaç: Bu çalışmanın amacı; multipl skleroz (MS) hastalarında apati ve emosyonel labilite gibi nöropsikiyatrik semptomları ve bunların eşlik eden diğer faktörlerle ilişkisini kapsamlı bir şekilde değerlendirmektir. Gereç ve Yöntem: 258 MS hastasına Montreal bilişsel değerlendirme (MoCA), Apati değerlendirme ölçeği (AES), Yorgunluk şiddeti ölçeği (FSS), Emosyonel Labilite (CNS-LS), Beck Depresyon Envanteri (BDI) uygulandı. Ölçekler ve diğer olası nedenler arasında korelasyon ve regresyon analizleri yapıldı. Bulgular: Hastaların %53,6'sında emosyonel labilite, %76.2'sinde yorgunluk mevcuttu. Emosyonel labilite ile yorgunluk ve depresyon arasında pozitif korelasyon izlenirken, apati ile emosyonel labilite ve yorgunluk arasında negatif korelasyon saptandı. Ek olarak, apati ve depresyon arasında negatif korelasyon izlendi. Bilişsel bozukluk ile depresyon ve/veya hastalık süresi ve/veya diğer ölçek puanları arasında ilişki yoktu. Sonuç: Emosyonel labilite ve apati, MS hastalarında oldukça sık görülen ve birbiriyle kesişen/karışan sorunlardır. Buna ek olarak; apati, MS hastalarında ortaya çıkan bağımsız bir nöropsikiyatrik semptom olabilir.

Keywords

MS apati psödobulbar etkiler apathy pseudobulbar affect

🔖

Cite This Article

ONER, O. G., TOTUK, O., DOGAN, İ. G., CELİK, D., DEMİR, S. (2022). Evaluation of neuropsychiatric symptoms in patients with multiple sclerosis. Cukurova Medical Journal, Cilt: 47 - Sayı: 1, 208–218. https://ajindex.com/articles/395732

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (15)

Demir S, Tutuncu M, Uzunkopru C, Gumus H, Sen S, Gunduz T et al. A comprehensive assessment of patient experience and disease-related awareness in Multiple Sclerosis: A questionnaire-based nation-wide survey in Turkey. Mult Scler Relat Disord. 2021;52:103005
Pandya R, Metz L, Patten SB. Predictive value of the CES-D in detecting depression among candidates for disease-modifying multiple sclerosis treatment. Psychosomatics. 2005;46:131-4
Moore P, Harding KE, Clarkson H, Pickersgill TP, Wardle M, Robertson NP. Demographic and clinical factors associated with changes in employment in multiple sclerosis. Mult Scler. 2013;19:1647-54
Fiest KM, Walker JR, Bernstein CN, Graff LA, Zarychanski R, Abou-Setta AM et al. Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis. Mult Scler Relat Disord. 2016;5:12-26
Feinstein A, Magalhaes S, Richard JF, Audet B, Moore C. The link between multiple sclerosis and depression. Nat Rev Neurol. 2014;10:507-17
Bonelli RM, Cummings JL. Frontal-subcortical circuitry and behavior. Dialogues Clin Neurosci. 2007;9:141-51
Fitzgerald KC, Salter A, Tyry T, Fox RJ, Cutter G, Marrie RA. Pseudobulbar affect: prevalence and association with symptoms in multiple sclerosis. Neurol Clin Pract. 2018;8:472-481
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G et all. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17:162-173
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology. 1983;33:1444–52
Sullivan MJ, Weinshenker B, Mikail S, Bishop SR. Screening for major depression in the early stages of multiple sclerosis Can J Neurol Sci. 1995;22:228-31
Quaranta D, Marra C, Zinno M. Presentation and validation of the Multiple Sclerosis Depression Rating Scale: a test specifically devised to investigate affective disorders in multiple sclerosis patients. Clin Neuropsychol. 2012;26:571–587
Hisli N. Beck Depresyon Envanteri’nin geçerliği üzerine bir çalışma. Psikoloji Dergisi. 1988;6:118-26
Beck AT, Steer RA, Brown GK. Manual for the Beck depression inventory-II. San Antonio, TX: Psychological Corporation. 1996
Krupp, LB, LaRocca NG, Muir-Nash J, Steinberg AD. The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121-3
Armutlu K, Kork